New Incyte Head Says Clinical Trials at Least Three Years Out | GenomeWeb

SAN FRANCISCO, Jan. 7 - The newly appointed CEO of Incyte Genomics said on Monday that medicinal chemists will be the most important group to help the company launch its new drug-discovery program.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.